Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults.
Nat Microbiol
; 7(2): 195-199, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-35013593
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunity, Humoral
/
Immunogenicity, Vaccine
/
SARS-CoV-2
/
COVID-19
/
BNT162 Vaccine
/
Immunity, Cellular
/
Antibodies, Viral
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
Nat Microbiol
Year:
2022
Document type:
Article
Affiliation country:
Germany